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ABSTRACT Phosphorylation of G-protein-coupled re-
ceptors plays an important role in regulating their function.
In this study the G-protein-coupled receptor phosphatase
(GRP) capable of dephosphorylating G-protein-coupled re-
ceptor kinase-phosphorylated receptors is described. The
GRP activity of bovine brain is a latent oligomeric form of
protein phosphatase type 2A (PP-2A) exclusively associated
with the particulate fraction. GRP activity is observed only
when assayed in the presence of protamine or when phos-
phatase-containing fractions are subjected to freeze/thaw
treatment under reducing conditions. Consistent with its
identification as a member of the PP-2A family, the GRP is
potently inhibited by okadaic acid but not by 1-2, the specific
inhibitor of protein phosphatase type 1. Solubilization of the
membrane-associated GRP followed by gel filtration in the
absence of detergent yields a 150-kDa peak of latent receptor
phosphatase activity. Western blot analysis of this phos-
phatase reveals a likely subunit composition of ABaC. PP-2A
of this subunit composition has previously been characterized
as a soluble enzyme, yet negligible soluble GRP activity was
observed. The subcellular distribution and substrate speci-
fi'city of the GRP suggests significant differences between it
and previously characterized forms of PP-2A.
Exposure of the f32-adrenergic receptor (,BAR) receptor to
agonists results in a rapid decline in receptor responsiveness,
a process that appears to involve receptor phosphorylation (1,
2). In addition to the second messenger-dependent protein
kinases (1), agonist-specific phosphorylation of this receptor
can also be effected by the P3AR kinase (PARK), a member of
the family of second messenger-independent G-protein-
coupled receptor kinases (GRKs).
Despite the considerable progress that has been made in
identifying and characterizing the mechanism of action of
,BARK, little is known of the phosphatases responsible for
reversing this phosphorylation event. Resensitization, presum-
ably due to dephosphorylation of the ,BAR, has been shown to
occur rapidly upon removal of agonists (3). Regulation of
receptor phosphatase activity, therefore, represents an impor-
tant potential mechanism for modulating receptor function.
In this study, we characterize the f3ARK-phosphorylated P3AR
phosphatase present in extracts ofbovine brain. This phosphatase
activity, which is also capable of dephosphorylating ,BARK-
phosphorylated a2C2-adrenergic receptors (a2C2ARs) and rho-
dopsin kinase (RK)-phosphorylated rhodopsin, is termed the
G-protein-coupled receptor phosphatase (GRP). The enzyme,
an oligomeric form of protein phosphatase type 2A (PP-2A), is
latent and specifically associated with the particulate fraction.
MATERIALS AND METHODS
Preparation of 32P-Labeled Substrates. Purified reconsti-
tuted P3AR (200 nM) (4-6) was phosphorylated (500-,ul reac-
tion volume) with purified PARK, PAR kinase 2 (I3ARK-2),
RK (7), or cAMP-dependent protein kinase (PKA) (125 nM)
as described (8). Reactions were terminated after incubation
at 30°C for 20 min by addition of 1 ml of ice-cold 50 mM
Tris-HCl, pH 7.0/0.1 mM EDTA/50 mM 2-mercaptoethanol
(buffer A). Labeled receptor was centrifuged (350,000 x g for
15 min), washed three times, and resuspended in buffer A.
Stoichiometries of phosphorylation were 2-4 mol of Pi per mol
of J3AR for P3ARK or ,3ARK-2, 1-2 mol of Pi per mol of ,BAR
for RK, and 1.5-1.7 mol of Pi per mol of ,BAR for PKA.
Purified Sf9 cell membranes containing human PAR or
a2C2AR and rod outer segment membranes (9, 10) were
phosphorylated as described for the purified P3AR. The ,BAR
and a2C2AR were phosphorylated by using the ,BARK and
rhodopsin was phosphorylated by using RK to stoichiom-
etries of 3.0, 3.2, and 4.0 mol of Pi per mol of receptor,
respectively. Phosphorylase a was prepared as in ref. 11.
Phosphatase Assays. To assess GRP activity, 32P-labeled
P3AR (1.0 pmol) was incubated with a source of phosphatase
in buffer A in 30 ,lI. Incubations were performed at 30°C for
the times indicated. Dephosphorylation reactions were termi-
nated by the addition of SDS sample loading buffer and
proteins were separated on SDS/10% polyacrylamide gels.
Phosphorylated P'AR was visualized by autoradiography and
quantified by phospho imager analysis. Okadaic acid (OA) (5
,uM) was included in a control incubation to eliminate the
possibility that proteolysis contributes to the loss of 32P-labeled
receptor.
Phosphorylase a phosphatase assays were performed as
described in ref. 12. To determine protein phosphatase type 1
(PP-1) and PP-2A activities, 1 nM OA was used to inhibit
PP-2A and 100 nM I-2, the recombinant rabbit skeletal muscle
inhibitor 2 (13), was used to inhibit PP-1. 1-2 at 100 nM and OA
at 1 nM or OA at 5 ,uM were used to inhibit both PP-1 and
PP-2A. Where indicated phosphatase-containing fractions
were subjected to freeze/thaw treatment in the presence of 0.2
M 2-mercaptoethanol prior to assay.
Sources of Protein Phosphatases. Frozen bovine cerebral
cortex (100 g) was homogenized in 500 ml of 50 mM Tris HCl,
pH 7.0/5 mM EDTA/50mM 2-mercaptoethanol (buffer B) at
4°C and passed through a double layer of cheesecloth. This
fraction, the homogenate, was centrifuged at 300,000 x g for
45 min yielding a supernatant containing soluble phosphatases
Abbreviations: GRP, G-protein-coupled receptor phosphatase; ,BAR,
132-adrenergic receptor; a2C2AR, a2C2-adrenergic receptor; GRK,
G-protein-coupled receptor kinase; f3ARK, PAR kinase; RK, rho-
dopsin kinase; PKA, cAMP-dependent protein kinase; PP-2A, protein
phosphatase type 2A; PP-1, protein phosphatase type 1; OA, okadaic
acid; munit(s), unit(s) x 10-3.
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(the soluble fraction) and a pellet of membrane-enriched
particulate matter. The particulate material was rehomog-
enized in buffer B containing 500 mM NaCl and extracted on
ice for 30 min. Centrifugation at 300,000 x g for 45 min yielded
a soluble salt-wash fraction that was concentrated and de-
salted. The remaining particulate material was resuspended in
25 ml of buffer B and is termed the particulate fraction.
Gel Filtration ofGRP Activity. The particulate fraction from
bovine brain was incubated with 0.25% dodecyl ,3-maltoside in
buffer B at 4°C for 45 min. Soluble proteins were recovered
after centrifugation at 350,000 x g for 10 min. Where indi-
cated, detergent was removed from this preparation by using
Extracti-Gel (Pierce) (5). Gel filtration was performed on a
Superose-12 column (10 x 300 mm) in 20 mM Tris-HCl, pH
7.0/2 mM EDTA/5% (vol/vol) glycerol/100 mM NaCl in the
presence or absence of 0.05% dodecyl ,B-maltoside. The col-
umn was developed at a flow rate of 0.3 ml/min and 0.3-ml
fractions were collected.
Immunoblot Analysis. Western blot analysis of GRP-
containing fractions was performed by using rabbit antisera
directed against the catalytic subunit (14), the structural A
subunit (15) and regulatory B subunits [Ba (16), Bp (16), and
B' (17)] of PP-2A, and the ECL kit (Amersham). Purified
PP-2A (16) and a lysate of Sf9 cells overexpressing the Bp
subunit were used as positive controls.
RESULTS AND DISCUSSION
The Principle GRP Activity of Bovine Brain Is a Latent
Form of PP-2A. A homogenate of bovine brain was prepared
and assayed for its ability to dephosphorylate ,BARK-
phosphorylated ,3AR. Surprisingly, negligible spontaneous
receptor phosphatase activity was observed (Fig. 1), although
both PP-1 [0.28 x 10-3 unit (munit)/mg of protein] and PP-2A
(0.5 munit/mg of protein) activities could be detected by using
phosphorylase a as a substrate. Similarly, negligible receptor
phosphatase activity was detected when assays were per-
formed in the presence of 5 mM Mg2+, 0.1 mM Ca2+, or
Ca2+/calmodulin (0.1 mM/0.2 ,uM), indicating that the cation-
dependent phosphatases PP-2C and PP-2B do not play a role
in dephosphorylating this substrate (Fig. 1B). Potent GRP
activity was, however, observed upon addition of protamine or
after a freeze/thaw treatment of the extract in the presence of
2-mercaptoethanol (Fig. 1). These treatments have been
shown to potently activate PP-2A (18). The initial rate of
dephosphorylation of the ,BAR when assayed in the presence
of protamine after a freeze/thaw treatment was -0.4 mol of
Pi released per mol of ,BAR per min with 75% of the substrate
being dephosphorylated after 10 min. Addition of I-2 (100
nM), a potent and selective inhibitor of PP-1, inhibited 40% of
the total phosphorylase a phosphatase activity but had no
effect on either the protamine or freeze/thaw-stimulated
receptor phosphatase activity (Fig. 1). Furthermore, OA po-
tently inhibited freeze/thaw-activated GRP activity with an
IC50 of 0.1 nM (data not shown), consistent with reported
values for the catalytic subunit of PP-2A (19). The GRP
activity of bovine brain would, thus, appear to be a low-activity
oligomeric form of PP-2A.
The GRP Activity Is Membrane-Associated. To assess the
intracellular distribution of the receptor phosphatase, soluble,
particulate, and salt-wash fractions were prepared from the
bovine brain homogenate and assayed for GRP activity. The
receptor phosphatase activities of the fractions were assayed at
approximately equivalent phosphorylase a phosphatase activ-
ities (0.05 munit/ml). As described (Fig. 1) negligible receptor
phosphatase activity was observed in any fraction in the
absence of activators of PP-2A. Freeze/thaw treatment in the
presence of 2-mercaptoethanol revealed significant GRP ac-
tivity in the homogenate, which was exclusively associated with
the particulate fraction (Fig. 2). The latency and membrane
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FIG. 1. GRP activity of a bovine brain homogenate. (A) GRP
assays were performed with no additions (0) or in the presence of
protamine sulfate (1 mg/ml) (A). After freeze/thaw treatment (F/T)
of the homogenate, assays were performed in the presence (a) or
absence (0) of protamine sulfate (Prot., 1 mg/ml) or in the presence
of 100 nM 1-2 (o). Assays were performed at a phosphorylase a
phosphatase activity of 0.1 munit/ml. The results shown represent the
mean ± SEM for three experiments. (B) Autoradiograph showing the
effects of various treatments on GRP activity. Samples were incubated
for 30 min at 30°C and subsequently electrophoresed on SDS/10%
polyacrylamide gels. The band corresponding to phosphorylated P3AR
is shown. Assays contained the following additions, where indicated:
protamine, 1 mg/ml; 1-2, 100 nM; OA, 5 ,iM; Mg2+, 5 mM; Ca2+, 0.1
mM; Ca2+/calmodulin, 0.1 mM/0.2 ,LM. The effect of freeze/thaw
treatment of the homogenate is also shown (F/T).
localization of the GRP distinguish this enzyme from the
spontaneously active soluble PP-2A reported to dephospho-
rylate rhodopsin (20-22) and the cholecystokinin receptors
(23). However, previous studies failed to assess the receptor
phosphatase activity of the salt-washed particulate fraction.
Additionally, when assessing cholecystokinin receptor dephos-
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FIG. 2. Receptor phosphatase activity is associated with the par-
ticulate fraction. The GRP activities of a bovine brain homogenate (0)
and three fractions derived from this extract, a soluble fraction (LI), a
salt-wash fraction (A), and a particulate fraction (a), were compared.
Fractions were subjected to freeze/thaw treatment in the presence of
0.2 M 2-mercaptoethanol prior to assay. The extract, soluble, and
salt-extracted fractions were assayed at a spontaneous phosphorylase
a phosphatase activity of 0.1 munit/ml, and the particulate fraction
was assayed at a phosphorylase a phosphatase activity of 0.05 munit/
ml. The data shown represent the mean ± SEM of three experiments.
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phorylation, pancreatic cells were lysed and phosphatase as-
says were performed in the presence of detergent, conditions
favoring dissociation of the latent GRP (23). A role for the
latent membrane-associated GRP in the dephosphorylation of
these receptors (rhodopsin and cholecystokinin) cannot, there-
fore, be discounted.
The particulate localization of the GRP was a somewhat
surprising finding since PP-2A is generally considered to be a
soluble enzyme. That PP-2A phosphatase activity was indeed
present in the particulate fraction was confirmed by using
phosphorylase a as a substrate. OA and I-2 were used to
determine the relative activities of PP-1 and PP-2A in each of
the fractiohs assayed for GRP (Table 1). As expected, the
bovine brain homogenate cottained approximately equal
amounts of spontaneously active PP-1 and PP-2A phosphatase
activity. The soluble fraction was predominantly PP-2A (85%)
and the salt-extracted fraction PP-1 (85%). The particulate
fraction cqntained little spontaneous phosphatase activity
(0.25 munit/mg of protein).
Freeze/thaw treatment under reducing conditions dissoci-
ates oligomeric forms of PP-2A and leads to an activation of
this enzyme (18). This treatment thus activates the PP-2A in
both the homogenate and the soluble fractions (Table 1).
Interestingly, the particulate fraction, which contains the GRP
activity, but very little spontaneously active PP-2A, displays the
largest fold increase in PP-2A-like activity upon freeze/thaw
treatment. After freeze/thaw activation, the phosphorylase a
phosphatase activity of this fraction increases -9-fold. Thus a
pool of latent PP-2A, including the GRP, is tightly associated
with the particulate fraction.
The presence of latent PP-2A and PP-1 in a crude synaptic
plasma membrane preparation derived from rat forebrain was
recently reported (24). Extraction of the membranes with 500
mM NaCl and 0.3% Triton X-100 resulted in the elution and
activation of both enzymes (24). In this study, treatment of the
membrane fraction with 500 mM NaCl alone released mem-
brane-associated PP-1 but not PP-2A activity (Table 1), sug-
gesting different mechanisms of membrane association for
these two classes of serine/threonine protein phosphatases.
Substrate Specificity of GRP. To investigate the receptor
specificity of the GRP activity, the ability of this enzyme to
dephosphorylate three GRK-phosphorylated G-protein-coupled
receptors,was investigated. Purified Sf9 cell membranes contain-
ing ,ARK-phosphorylated PAR or a2C2AR or rod outer seg-
ment membranes containing RK-phosphorylated Fhodopsin were
utilized as substrates for the GRP. All three GRK-phosphory-
lated receptors were dephosphorylated in an 1-2-resistant fashion
after freeze/thaw activation of the particulate fraction (Fig. 3A).
The GRP would thus appear to have a broad specificity for
GRK-phosphorylated G-protein-coupled receptors.
Does the GRP exhibit specificity for particular phosphory-
lation sites? To examine this question, the ability of the
salt-washed particulate fraction to dephosphorylate GRK- or
Table 1. Distribution of PP-1 and PP-2A enzyme activities in
bovine brain extracts
Phosphorylase a phosphatase activity,
munits/mg of protein
Freshly Freeze/thaw
prepared activated
Extract PP-2A PP-1 PP-2A PP-1
Homogenate 0.5 0.281 2.75 0.35
Soluble 1.13 0.198 2.1 0.3
Salt wash 0.495 2.81 0.46 1.89
Particulate 0.125 0.125 2.08 0.17
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FIG. 3. Substrate specificity of the GRP. (A) The GRP activity of
the particulate fraction assayed against ,BARK-phosphorylated P3AR,
f3ARK-phosphorylated a2C2AR, and RK-phosphorylated rhodopsin.
Assays were performed by using untreated particulate material in the
presence or absence of 5 IuM OA (+ okadaic acid, no additions) or
using freeze/thaw-treated particulate material in the presence or
absence of 100 nM I-2. The receptor substrates are indicated. All
assays were performed at a phosphorylase a phosphatase activity of
0.05 munit/ml. The data shown represent the mean ± SEM for three
experiments. (B) GRP activity of a salt-washed particulate fraction
assessed by using as substrates purified reconstituted P3AR phos-
phorylated with P3ARK (2.7 ± 0.3 mol of Pi per mol of ,BAR), ,BARK-2
(3.1 ± 0.5 mol of Pi per mol of P3AR), RK (1.5 ± 0.5 mol of Pi per mol
of PAR), or PKA (1.6 ± 0.1 mol of Pi per mol of PAR). Assays were
performed at a phosphorylase a phosphatase activity of 0.05 munit/
ml by using untreated particulate material in the presence or absence
of 5 ,uM OA or after freeze/thaw treatment of the phosphatase
preparation, in the presence of protamine (1 mg/ml), or in the
presence of protamine (1 mg/ml) and 100 nM I-2. The data shown
represent the mean ± SEM for three experiments.
PKA-phosphorylated PAR substrates was examined. ,ARK-
1,2 and RK but not PKA-phosphorylated PAR served as
substrates for the activated GRP (Fig. 3B). Dephosphorylation
was unaffected by 1-2 addition. Thus the membrane-associated
GRP dephosphorylates a number of G-protein-coupled recep-
tors; moreover, for the P3AR, those sites phosphorylated by
GRKs rather than PKA appear to be the preferred substrates
for this enzyme.
Resolution of Two Forms of the GRP by Gel Filtration. To
gain information concerning the structure of the GRP, deter-
gent-solubilized preparations derived from the particulate
fraction of bovine brain were subjected to gel filtration on
Superose-12 (Fig. 4). The solubilized preparation exhibited
spontaneous GRP activity when assayed in the presence of
detergent (Fig. 44). Removal of detergent, however, resulted
Samples were assayed before or after freeze/thaw treatment. The
results shown represent the mean of six determinations performed on
three bovine brain preparations.
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FIG. 4. Gel filtration of the receptor phosphatase activity. The
detergent-solubilized particulate fraction was subjected to gel filtra-
tion on a Superose-12 column in the presence of detergent (0.05%
dodecyl f3-maltoside) (A). Alternatively, prior to gel filtration, deter-
gent was removed from the solubilized fraction and gel filtration was
performed in the absence of detergent (B). Fractions were assayed for
phosphorylase a phosphatase (0) and GRP activity. GRP activity was
measured in the presence (0) or absence (o) of protamine sulfate (1
mg/ml). The elution positions of aldolase (158 kDa), ovalbumin (43
kDa), and chymotrypsinogen A (25 kDa) are indicated.
in the formation of a GRP activity with properties similar to
those of the native enzyme; i.e., the enzyme was inactive in the
absence of protamine (Fig. 4B). Gel filtration, in the presence
of detergent, revealed a major peak of both phosphorylase a
phosphatase and GRP activities. The receptor phosphatase
activity was spontaneous, inhibited by 2 nM OA, and stimu-
lated by protamine. Furthermore, by gel filtration, it had an
apparent molecular mass of 35 kDa, observations consistent
with the identification of the catalytic subunit of the GRP as
the catalytic subunit of PP-2A (Fig. 4A4).
Gel filtration of the solubilized latent form of the GRP (i.e.,
in the absence of detergent) revealed no spontaneous activity
(Fig. 4B). However, two peaks of GRP activity, with apparent
molecular masses of 150 kDa and 35 kDa, were observed when
the fractions were assayed in the presence of protamine (Fig.
4B). Thus removing detergent appears to promote the reas-
sociation of the catalytic subunit of the GRP with one or more
regulatory subunits. At equivalent phosphorylase a phos-
phatase activities, the receptor phosphatase activity of the
oligomeric enzyme is "4-fold higher than that of the free
catalytic subunit.
The free catalytic subunit of the GRP displays spontaneous
receptor phosphatase activitywhen assayed in the presence but
not the absence of detergent (Fig. 4). This apparent difference
in GRP latency is specific to the PAR substrate since the
phosphorylase a phosphatase activity of the 35-kDa GRP is
similar in either the presence or absence of detergent. Thus
receptor conformation appears to play a role in regulating
receptor dephosphorylation. The latency of the GRP may thus
potentially be overcome by direct activation of this enzyme or,
alternatively, by alteration of the conformation of its receptor
substrates.
In a previous study (25), the ability of various purified
preparations of phosphatase catalytic subunits to dephosphor-
ylate the P3AR was investigated. Of the purified phosphatase
catalytic subunits utilized, PP-2A, PP-1, PP-2B, and the cata-
lytic subunit of a latent high molecular weight phosphatase
LP-2, only the latter was capable of dephosphorylating ,ARK-
phosphorylated P3AR. Although LP-2 shares some properties
with the GRP-namely, its latency-it is a soluble enzyme with
a subunit molecular mass of 49 kDa and, thus, seems unlikely
to account for the GRP activity of bovine brain homogenates.
Immunological Analysis of the GRP. PP-2A holoenzymes
have been demonstrated to exist as a heterotrimeric complex
consisting of a 36-kDa catalytic subunit (C), a 65-kDa struc-
tural subunit (A), and a third regulatory subunit ranging in
molecular mass between 52 and 74 kDa (26). In an attempt to
gain information concerning the relationship between the
GRP and previously characterized forms of PP-2A, fractions
containing the 150-kDa GRP activity, (Fig. 4B, fractions
36-38) were pooled and subjected to immunoblot analysis.
Polyclonal antibodies specific for the catalytic (36 kDa), A (65
kDa), and three distinct B subunits [Ba (55 kDa), Bp (55 kDa),
and B' (53 kDa)] of PP-2A were utilized. As shown in Fig. 5,
immunoreactive species of appropriate molecular masses were
observed in the GRP fraction blotted with either the catalytic
subunit (Fig. SA) or A subunit (Fig. SB) antibodies. Of the
three B-subunit antibodies utilized, only that raised against a
peptide corresponding to residues 14-26 of the human PP-2A
A B
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35- - _
29.7-
GRP GRP
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143-
97-
50-- *.rn_...cobHS_
35-
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FIG. 5. Immunoblot analysis of the 150-kDa GRP activity. Frac-
tions containing the large molecular mass form of the GRP activity
(Fig. 4B, fractions 36-38) were pooled and subjected to Western blot
analysis with rabbit antisera directed against the catalytic subunit
(anti-C) (A), the structural A subunit (anti-A) (B), and three regula-
tory B subunits, Ba (anti-Ba) (C), Bp (anti-Bp) (D), and B' (anti-B')(E) of PP-2A. Each panel contains two lanes, a control lane (unla-
beled) for the antisera containing the protein against which the
antibody is directed and a lane containing the pooled GRP fractions
(labeled GRP).
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subunit Bc. displayed immunoreactivity with a protein of
appropriate molecular mass in the GRP-containing fraction
(Fig. SC). These results support the identification of the GRP
as an oligomeric form of PP-2A and suggest a potential subunit
structure of ABaC. Interestingly, PP-2A of this subunit com-
position, the most prevalent soluble form of PP-2A in bovine
brain extracts (27), was recently identified as the principle
soluble rhodopsin phosphatase of rod outer segments (28).
However, we observe negligible soluble GRP activity. Thus
although apparently composed of immunologically similar
subunits, two prominent characteristics distinguish the GRP
from soluble bovine brain PP-2A-namely, its particulate
localization and substrate specificity. What potentially could
account for these differences? The Ba subunit antibodies
utilized in this study were raised against a short peptide
sequence derived from this protein (16). The GRP may thus
contain a regulatory B subunit highly related to but distinct
from Ba. Alternatively, since two isoforms (a and 13) of the C
and A subunits of PP-2A have been identified (29-31), the
GRP and soluble PP-2A may have different isoform composi-
tions. Finally, covalent modifications of the catalytic subunit of
PP-2A have been reported including phosphorylation (32, 33)
and carboxyl methylation (34). Differential post-translational
modification of one or more of the constituent subunits of the
GRP may account for the altered properties of this enzyme.
In conclusion, GRP, a latent membrane-associated form of
PP-2A representing the principle PAR phosphatase activity of
bovine brain, has been identified. Immunological analysis
suggests a potential subunit structure for the GRP of ABaC;
however, significant differences exist between the GRP and
the previously characterized soluble PP-2A of this composi-
tion. The reasons for the particulate localization of the GRP
remain obscure; however, the latency and localization of this
enzyme suggest that it may represent an important regulatory
target for modulating the phosphorylation state of membrane-
associated receptors.
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